We just received data on a new analyst forecast for $XENE. Serge Belanger from Needham set a price target of 78.0 for XENE.
To track analyst ratings and price targets for $XENE, check out Quiver Quantitative's $XENE forecast page.
Should you buy $XENE?
Some analysts are better than others. To view the past performance of Needham, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$XENE Price Targets
Multiple analysts have issued price targets for $XENE recently. We have seen 8 analysts offer price targets for $XENE in the last 6 months, with a median target of $71.0.
Here are some recent targets:
- Serge Belanger from Needham set a target price of $78.0 on 05/08/2026
- Laura Chico from Wedbush set a target price of $63.0 on 03/16/2026
- David Hoang from Deutsche Bank set a target price of $90.0 on 03/10/2026
- Douglas Tsao from HC Wainwright & Co. set a target price of $74.0 on 03/10/2026
- Benjamin Burnett from Wells Fargo set a target price of $68.0 on 03/10/2026
- Brian Skorney from Baird set a target price of $97.0 on 03/09/2026
- Rudy Li from Wolfe Research set a target price of $60.0 on 02/24/2026
$XENE Insider Trading Activity
$XENE insiders have traded $XENE stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $XENE stock by insiders over the last 6 months:
- IAN MORTIMER (PRESIDENT & CEO) has made 0 purchases and 17 sales selling 353,879 shares for an estimated $20,294,055.
- CHRISTOPHER JOHN KENNEY (Chief Medical Officer) has made 0 purchases and 2 sales selling 4,181 shares for an estimated $244,426.
- ANDREA DIFABIO (Chief Legal Officer) has made 0 purchases and 2 sales selling 3,949 shares for an estimated $230,813.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$XENE Hedge Fund Activity
We have seen 141 institutional investors add shares of $XENE stock to their portfolio, and 94 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BRAIDWELL LP removed 1,779,953 shares (-49.4%) from their portfolio in Q4 2025, for an estimated $79,777,493
- WELLINGTON MANAGEMENT GROUP LLP added 1,154,922 shares (+32.0%) to their portfolio in Q4 2025, for an estimated $51,763,604
- COMMODORE CAPITAL LP removed 900,000 shares (-33.3%) from their portfolio in Q4 2025, for an estimated $40,338,000
- DEEP TRACK CAPITAL, LP removed 833,565 shares (-69.5%) from their portfolio in Q4 2025, for an estimated $37,360,383
- PRICE T ROWE ASSOCIATES INC /MD/ added 820,608 shares (+1968.3%) to their portfolio in Q4 2025, for an estimated $36,779,650
- MILLENNIUM MANAGEMENT LLC removed 748,951 shares (-54.1%) from their portfolio in Q4 2025, for an estimated $33,567,983
- HOLOCENE ADVISORS, LP removed 694,472 shares (-35.1%) from their portfolio in Q4 2025, for an estimated $31,126,235
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
